Coronavirus: early signs Sinovac’s jab is safe and effective in children

Auteur : Zhuang Pinghui, journalistes du South China Morning Post à Pékin

Production : South China Morning Post, quotidien de langue anglaise publié à Hong Kong depuis 1903. Sa diffusion s’élève à 104 000 exemplaires. Il est publié par le groupe SCMP, propriété de du groupe Alibaba depuis 2015.

Diffusion : site du journal South China Morning Post

Date et Heure : 29 juin 2021, 06:30

– Chinese company says initial studies indicate that CoronaVac induced antibodies in more than 96 per cent of trial participants

– Immune responses among children and teenagers were higher than adults assessed in previous studies, researchers say

Source : Zhuang Pinghui, “Coronavirus: early signs Sinovac’s jab is safe and effective in children”, South China Morning Post, 29/06/2021. URL : https://www.scmp.com/news/china/science/article/3139078/early-signs-sinovacs-covid-19-jab-safe-and-effective-children (consulté le 30/06/2021).

Article de référence :

Bihua Han, Yufei Song, Changgui Li [et al.], “Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial”, The Lancet, 28/06/2021. DOI : https://doi.org/10.1016/S1473-3099(21)00319-4 (consulté le 30/06/2021)

Photo “à la une” : Sinovac coronavirus vaccine is applying for a late-stage trial for children. © Xinhua

---

---